top selling glp-1 drugs Pharma's Top-Selling in Q1 2025: Oncology, Immunology, and | Pharmint posted on the topic Pharma Giants Bet on Next-Generation

The above three experiments were investigated at the cellular, animal, and clinical levels, and it is believed that GLP-1RA has an inhibitory effect on breast cancer

Clinical studies (in both obesity and type 2 diabetes) consistently show that GLP-1 RA treatment leads to less hunger, increased satiety, and spontaneous decreases in daily caloric consumption (Zheng et al., 2024)

Glucagon-Like Peptide-1 Induces Cell Proliferation and Pancreatic-Duodenum Homeobox-1 Expression and Increases Endocrine Cell Mass in the Pancreas of Old, Glucose-Intolerant Rats

Five clinical trials (SURPASS 1-5 trials) conducted in patients with T2DM showed that tirzepatide at 5-15 mg per week could reduce body weight (5.4-11.7kg), which was never seen with a single drug (129)

[48] Pancreatic and thyroid safety [edit] Historically, GLP-1 receptor agonists have carried warnings regarding acute pancreatitis and pancreatic cancer